Global Structural Heart Devices Market to Achieve USD 28.84 Billion by 2033, According to DataM Intelligence

Overview of the Market:

The Global Structural Heart Devices Market is witnessing rapid transformation, fueled by the rising prevalence of cardiovascular diseases, increased adoption of minimally invasive procedures, and technological advancements in device design and functionality. Structural heart devices are critical in treating heart defects such as aortic stenosis, mitral regurgitation, and atrial septal defects, which are becoming increasingly common with aging populations and lifestyle-related health conditions. The industry has evolved beyond traditional open-heart procedures toward less invasive, catheter-based therapies that improve patient recovery rates, reduce hospital stays, and deliver better long-term outcomes.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/structural-heart-devices-market?sz

According to DataM Intelligence, The Global Structural Heart Devices Market was valued at USD 14.79 billion in 2024 and is projected to reach USD 28.84 billion by 2033, growing at a robust CAGR of 8.0% during 2025-2033. Transcatheter aortic valve replacement (TAVR) currently represents the leading product segment due to its success in addressing aortic valve stenosis with minimally invasive techniques. Geographically, North America dominates the market, supported by high adoption rates of advanced cardiac procedures, strong reimbursement frameworks, and the presence of global medtech leaders. Meanwhile, Asia-Pacific is emerging as a high-growth region, driven by a growing patient pool and healthcare infrastructure modernization.

Key Highlights from the Report:

➤ Global market expected to nearly double in value from 2025 to 2033 with a CAGR of 8.0%.
➤ Transcatheter aortic valve replacement (TAVR) is the fastest-growing segment due to its minimally invasive benefits.
➤ North America remains the dominant region, supported by advanced healthcare systems and favorable reimbursement policies.
➤ Asia-Pacific is projected to experience the fastest growth, driven by rising cardiovascular disease incidence and expanding hospital networks.
➤ Major companies are focusing on strategic mergers, acquisitions, and collaborations to strengthen portfolios.
➤ Technological innovation in structural heart devices is improving patient outcomes and expanding applications.

Market Segmentation:

The Structural Heart Devices Market is segmented based on product type, procedure type, and end-user. By product type, the market is classified into heart valves, annuloplasty rings, occluders, and accessories. Among these, transcatheter heart valves dominate due to their high adoption in treating aortic stenosis. Occluders are also gaining traction as safe and effective solutions for atrial septal defect (ASD) and patent foramen ovale (PFO) closure.

By procedure type, the market covers TAVR, transcatheter mitral valve repair (TMVR), left atrial appendage closure (LAAC), and others. TAVR leads the market due to its minimally invasive nature and its strong adoption in elderly patients who are unfit for traditional open-heart surgery. TMVR is expected to grow significantly as device innovation addresses unmet needs in mitral valve diseases.

End-users include hospitals, specialty cardiac centers, and ambulatory surgical centers. Hospitals account for the largest share owing to advanced infrastructure, skilled cardiologists, and availability of hybrid operating rooms that integrate imaging and interventional facilities.

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=structural-heart-devices-market

Regional Insights:

North America holds the largest share of the structural heart devices market, with the U.S. being a key contributor. This dominance is supported by high diagnosis rates of structural heart diseases, robust reimbursement frameworks, and the widespread adoption of cutting-edge technologies like TAVR and LAAC. Europe follows closely, driven by initiatives to expand access to minimally invasive cardiovascular therapies and the presence of strong medical device regulations that ensure quality and safety.

The Asia-Pacific region is anticipated to grow at the highest CAGR over the forecast period. Countries like China, India, and Japan are witnessing increasing cases of cardiovascular diseases, fueled by aging populations and lifestyle shifts. Rapid investments in healthcare infrastructure, favorable government policies, and growing adoption of advanced surgical procedures are accelerating market expansion in the region. Meanwhile, Latin America and the Middle East & Africa are emerging markets with significant growth potential, though limited by economic and infrastructural constraints.

Market Dynamics:

Market Drivers

The rising burden of cardiovascular diseases globally is the most significant driver for the structural heart devices market. Lifestyle factors such as obesity, diabetes, and sedentary habits are contributing to increased incidences of heart-related conditions. The growing demand for minimally invasive procedures, which reduce patient recovery time and risk, is accelerating adoption. Additionally, technological innovations in device design and imaging techniques are enhancing surgical accuracy and patient outcomes.

Market Restraints

Despite promising growth, the market faces challenges such as the high cost of structural heart devices and procedures, which can limit adoption in low- and middle-income countries. Furthermore, stringent regulatory pathways for product approval and the risk of procedural complications pose barriers. Shortage of skilled interventional cardiologists in emerging regions also hampers market growth.

Market Opportunities

Significant opportunities exist in expanding access to structural heart therapies in emerging economies, where large patient populations remain underserved. Increased investment in R&D is likely to yield next-generation devices that are smaller, more durable, and easier to implant. Additionally, the growing integration of artificial intelligence and advanced imaging solutions into interventional cardiology is expected to revolutionize the precision and success rates of these procedures.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/structural-heart-devices-market

Reasons to Buy the Report:

✔ Gain detailed insights into global and regional structural heart devices market trends.
✔ Understand competitive strategies of key players and recent innovations.
✔ Access reliable market statistics and forecasts from DataM Intelligence.
✔ Identify high-growth segments and investment opportunities.
✔ Benefit from analysis of regulatory and reimbursement landscapes across regions.

Frequently Asked Questions (FAQs)

◆ How big is the structural heart devices market in 2024 and what is its growth outlook?
◆ Who are the key players in the global structural heart devices market?
◆ What is the projected CAGR of the structural heart devices market during 2025-2033?
◆ What is the forecast value of the structural heart devices market by 2033?
◆ Which region is expected to dominate the structural heart devices industry over the forecast period?

Company Insights:

Key players operating in the structural heart devices market include:

Medtronic
Abbott
JenaValve
Artivion, Inc
Boston Scientific Corporation
Micro Interventional Devices
Biomerics
TORAY INDUSTRIES, INC.
Occlutech LLC
Shanghai MicroPort Medical (Group) Co.Ltd.

Recent Developments:

In June 2025, a leading medtech company announced FDA clearance for its next-generation transcatheter mitral valve repair system, expanding options for patients with mitral regurgitation.

In July 2025, a global cardiac device manufacturer launched a new left atrial appendage closure (LAAC) device in Japan, marking its first availability in the Asia-Pacific market.

Conclusion:

The Structural Heart Devices Market is on a strong growth trajectory, driven by rising cardiovascular disease prevalence, technological innovations, and increasing adoption of minimally invasive procedures worldwide. North America leads the global market, but Asia-Pacific is rapidly emerging as a growth hub due to its expanding healthcare infrastructure and large patient pool. While high costs and regulatory challenges pose hurdles, opportunities in emerging economies, coupled with next-generation device development, are expected to fuel market expansion. For stakeholders, this market represents a vital intersection of medical innovation and growing global healthcare needs, offering significant potential in the coming years.

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.